AITSU is a startup that commercialises ultrasound guided intralymphatic Immunotherapy as a disruptive treatment for grass pollen allergy. To improve the quality of the injections, we want to build software that can identify lymph nodes and the needle in real time and guide the needle to the optimal site for the intralymphatic injection of medicine.